查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1629903

全球医疗保健保护包装市场 - 2025-2033

Global Healthcare Protective Packaging Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球医疗保健防护包装市场规模达53亿美元，预计2033年将达84亿美元，2025-2033年预测期间复合年增长率为5.3%。

医疗保健防护包装是指专门设计用于保护药品和医疗产品免受污染、物理损坏以及光、温度和湿度等环境因素影响的包装解决方案。这种类型的包装对于维持药品、医疗器材和生物製品从製造、储存到分销以及医疗保健提供者和患者使用的整个供应链的完整性、安全性和有效性至关重要。这些特性确保医疗保健防护包装符合监管和安全要求，并在整个供应链过程中保护敏感的药品。

医疗保健保护包装市场由多种因素推动，包括对药品和医疗器材的需求不断增长、包装技术的进步以及对产品安全性和功效的日益关注。例如，根据美国国立卫生研究院的数据，2023年美国食品药物管理局（FDA）批准了55种新药。慢性病的增加和全球人口老化导致医疗保健支出增加，从而增加了对保护性包装的需求，以确保药品和医疗器材在运输和储存过程中的完整性。

市场动态：

驱动程式和限制

对可持续发展的日益关注

对永续性的日益关注正在显着推动医疗保健防护包装市场的成长，预计将在预测期内推动市场的成长。消费者的偏好越来越倾向环保包装。随着医疗保健产品在全球范围内使用，尤其是在已开发市场，消费者期望包装解决方案能够最大限度地减少对环境的影响。向可回收和可生物降解材料的转变有助于公司满足这些期望并遵守永续发展目标。

在泡罩包装和单剂量容器中使用可生物降解塑胶正变得越来越普遍。 Klockner Pentaplast、Catalent 和 Berry Global 等公司透过推出和采用易于回收或堆肥的材料来引领这一转变。

例如，2024 年 10 月，Klockner Pentaplast (kp) 推出了 kpNext MDR1，这是一种新型医疗器材包装薄膜，将其 kpNext 品牌从药品泡罩膜扩展到医疗器材领域。这项突破性产品旨在满足医疗保健包装领域对永续包装选项不断增长的需求。

此外，2024 年 10 月，Berry Global 推出了一系列用于医疗保健应用的澄清聚丙烯 (PP) 瓶，与传统彩色 PET 药瓶相比，这些瓶可提供永续性并增强产品保护。 ClariPPil 瓶非常适合各种产品，包括维生素、营养保健品、膳食补充剂、美容补充剂和非处方药治疗。 Berry 报告称，与传统的 PET 瓶注拉吹成型工艺相比，其新的瓶子製造技术可减少约 71% 的二氧化碳排放量。

包装技术的进步正在促进向永续解决方案的转变。创新包括开发可回收玻璃和永续塑料，以及具有增强阻隔性能的包装，以在不影响环境绩效的情况下保持产品完整性。

例如，2024 年11 月，杜邦推出了具有可再生属性(RA) 的Tyvek，这是用于医疗保健包装的现有Tyvek 产品组合的延伸，可显着减少碳足迹，有助于实现更永续的医疗保健包装。透过在 Tyvek 製造所用原料的生产过程中以经过认证的生物循环原料部分取代化石燃料原料，可以减少具有可再生特性的 Tyvek 碳足迹。这是根据国际永续发展和碳认证 (ISCC PLUS) 透过品质平衡方法实现的。

严格的监理合规性

严格的监管合规性是医疗保健防护包装市场成长的重大障碍。 FDA 的 21 CFR 第 11 部分、欧盟 MDR 和其他区域标准等监管要求对材料、标籤和文件製定了严格的指导方针。合规性通常需要广泛的测试和认证流程，这对製造商来说可能既昂贵又耗时。

例如，为了满足这些标准，包装公司必须投资于复杂的可追溯系统、专用材料和灭菌技术，这会显着增加包装解决方案的成本。由于监管指南的变化，需要频繁更新包装设计，这使得成本结构更加复杂。

严格的审批流程可能会延迟新包装解决方案推向市场的时间。获得监管部门批准的漫长过程意味着新产品在到达消费者时往往面临延迟，这可能会影响竞争优势。例如，欧盟的医疗器材法规（MDR）要求製造商对包装设计进行严格的测试并获得认证，这可能需要数年时间。延长的时间可能会阻碍市场成长，因为公司必须等待推出新的合规产品。

目录

第一章：市场介绍和范围

  • 报告的目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按包装类型分類的片段
  • 按材料分类的片段
  • 按产品类型分類的片段
  • 按应用程式片段
  • 按地区分類的片段

第 3 章：动力学

  • 影响因素
    • 司机
      • 日益关注永续发展
      • 包装不断进步
    • 限制
      • 严格的监理合规性
    • 机会
    • 影响分析

第 4 章：策略洞察与产业展望

  • 市场领导者和先驱
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的知名领导者
    • 拥有成熟产品的市场领导者
  • 新兴新创企业和关键创新者
  • CXO 观点
  • 最新进展和突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：医疗保健保护包装市场（按包装类型）

  • 初级包装
  • 二次包装
  • 三级包装

第 6 章：医疗保健保护包装市场（按材料）

  • 塑胶
  • 纸和纸板
  • 玻璃
  • 铝

第 7 章：医疗保健保护包装市场，依产品类型

  • 瓶子和容器
  • 吸塑包装
  • 托盘
  • 小瓶
  • 注射器
  • 其他的

第 8 章：医疗保健保护包装市场（按应用）

  • 药品
  • 医疗器材
  • 诊断套件
  • 营养保健品

第 9 章：医疗保健保护包装市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的主要发展
  • 公司基准化分析

第 11 章：公司简介

  • SCHOTT Pharma AG & Co. KGaA
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT分析
  • Gerresheimer AG
  • Amcor plc
  • Berry Global Inc.
  • West Pharmaceutical Services, Inc.
  • Smurfit Kappa
  • Sonoco Products Company
  • WestRock Company
  • DuPont
  • Pregis LLC

第 12 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 13 章：附录

简介目录
Product Code: PAC8932

The global healthcare protective packaging market reached US$ 5.3 billion in 2024 and is expected to reach US$ 8.4 billion by 2033, growing at a CAGR of 5.3% during the forecast period 2025-2033.

Healthcare protective packaging refers to packaging solutions specifically designed to safeguard pharmaceutical and medical products from contamination, physical damage and environmental factors such as light, temperature and humidity. This type of packaging is crucial in maintaining the integrity, safety and efficacy of drugs, medical devices and biologics throughout the supply chain from manufacturing and storage to distribution and use by healthcare providers and patients. These characteristics ensure that healthcare protective packaging meets regulatory and safety requirements and protects sensitive pharmaceutical products during the entire supply chain process.

The healthcare protective packaging market is driven by several factors, including the increasing demand for pharmaceuticals and medical devices, advancements in packaging technologies and growing concerns over product safety and efficacy. For instance, according to the National Institute of Health, in 2023, 55 new drugs were approved by the U.S. Food and Drug Administration (FDA). The rise in chronic diseases and the aging global population are contributing to higher healthcare spending, boosting the need for protective packaging that ensures the integrity of drugs and medical devices during transport and storage.

Market Dynamics: Drivers & Restraints

Rising focus on sustainability

The rising focus on sustainability is significantly driving the growth of the healthcare protective packaging market and is expected to drive the market over the forecast period. Consumer preferences are increasingly oriented towards eco-friendly packaging. As healthcare products are used globally, especially in developed markets, consumers expect packaging solutions that minimize environmental impact. The shift towards recyclable and biodegradable materials helps companies meet these expectations and comply with sustainability goals.

The use of biodegradable plastics for blister packs and single-dose containers is becoming more common. Companies like Klockner Pentaplast, Catalent and Berry Global are leading this transition by launching and adopting materials that can be easily recycled or composted.

For instance, in October 2024, Klockner Pentaplast (kp), launched kpNext MDR1, a new medical device packaging film that expands its kpNext brand beyond pharmaceutical blister films and into the medical device sector. This breakthrough product is designed to meet the growing demand for sustainable packaging options in healthcare packaging.

Additionally, in October 2024, Berry Global launched a range of clarified polypropylene (PP) bottles for healthcare applications, which offer sustainability and enhanced product protection compared to traditional colored PET pill bottles. ClariPPil bottles are ideal for a wide variety of products including vitamins, nutraceuticals, dietary supplements, beauty supplements and OTC treatments. Berry reports that its new manufacturing technology for the bottle delivers a reduction of approximately 71% in CO2 emissions compared to the traditional injection stretch blow molding process for PET bottles.

Advancements in packaging technologies are facilitating the shift towards sustainable solutions. Innovations include the development of recyclable glass and sustainable plastics, as well as packaging with enhanced barrier properties to maintain product integrity without compromising on environmental performance.

For instance, in November 2024, DuPont launched Tyvek with Renewable Attribution (RA), an extension of the existing portfolio of Tyvek products for healthcare packaging that offers a significantly reduced carbon footprint, helping to enable more sustainable healthcare packaging. The carbon footprint reduction for Tyvek with Renewable Attribution is enabled by the partial replacement of fossil fuel feedstock with certified bio-circular feedstock during the production of raw materials used in Tyvek manufacturing. This is achieved through the mass balance approach, in accordance with International Sustainability and Carbon Certification (ISCC PLUS).

Stringent regulatory compliance

Stringent regulatory compliance is a significant barrier to the growth of the healthcare protective packaging market. Regulatory requirements such as the FDA's 21 CFR Part 11, EU MDR, and other regional standards mandate strict guidelines for materials, labeling and documentation. Compliance often requires extensive testing and certification processes, which can be costly and time-consuming for manufacturers.

For instance, to meet these standards, packaging companies must invest in sophisticated traceability systems, specialized materials, and sterilization techniques, which can significantly increase the cost of packaging solutions. The need for frequent updates to packaging designs due to changes in regulatory guidelines further complicates the cost structure.

Stringent approval processes can delay the introduction of new packaging solutions to the market. The lengthy process of obtaining regulatory approvals means that new products often face delays in reaching consumers, which can impact competitive advantage. For instance, the EU's Medical Device Regulation (MDR) requires manufacturers to conduct rigorous testing and obtain certifications for packaging designs, which can take years. This extended timeline can hinder market growth as companies must wait to introduce new, compliant products.

Segment Analysis

The global healthcare protective packaging market is segmented based on packaging type, material, product type, application and region.

Material:

The plastic segment is expected to dominate the healthcare protective packaging market share

Plastics provide excellent barrier properties such as moisture, light and chemical resistance, which are critical for maintaining the integrity of pharmaceuticals and medical devices during storage and transport. Blister packs and pouches made from plastic are widely used for packaging tablets, capsules and syringes. Their ability to protect against contamination and damage makes them a preferred choice for pharmaceuticals and medical devices.

For instance, in October 2024, Bayer launched a first-of-its-kind in the healthcare industry, polyethylene terephthalate (PET) blister packaging on its renowned brand, Aleve. Realized in partnership with pharma packaging specialist Liveo Research, this innovative solution reduces the carbon footprint of this packaging by 38% and marks a stride in environmental stewardship by eliminating the use of polyvinyl chloride (PVC).

Plastic is generally more cost-effective compared to other materials like glass and metal, making it suitable for mass production and meeting the demand for cost-efficient packaging solutions in the healthcare sector. Advancements in recycling technologies are making plastic a more sustainable option, especially with the development of recyclable and biodegradable plastics. Companies are increasingly adopting these solutions to meet regulatory requirements and consumer demand for greener products.

For instance, in October 2024, Placon released a new stock line of BargerGard TPU pouches and tip protectors. The new product line includes pouches with and without flaps and a variety of tip protectors to safeguard rough and sharp medical components, including catheters, needles, screws, drills and porous coated implants. The product line is made from thermoplastic polyurethane (TPU), a nonabrasive material that protects finished, polished, and other surfaces from damage, as well as preventing denting or scratching to devices and trays.

Geographical Analysis

North America is expected to hold a significant position in the healthcare protective packaging market share

North America has one of the most advanced healthcare infrastructures in the world, with well-established healthcare systems in countries like the United States and Canada. This infrastructure includes state-of-the-art facilities, a high rate of pharmaceutical consumption and a strong focus on medical research and development. These conditions necessitate high-quality protective packaging to maintain product integrity during distribution and storage.

For instance, according to the National Institute of Health (NIH), in 2021, overall pharmaceutical expenditures in the US grew 7.7% compared to 2020, for a total of $576.9 billion. Utilization (a 4.8% increase), price (a 1.9% increase) and new drugs (a 1.1% increase) drove this increase. For 2022, NIH expected overall prescription drug spending raised by 4.0% to 6.0%. This drug demand increases the demand for protective packaging in the region.

North America is at the forefront of adopting innovative packaging technologies, such as smart packaging and sustainable materials. Companies in this region are investing in technologies that provide enhanced barrier properties, tamper-evidence, and compliance with sustainability practices. This innovation drives demand for advanced protective packaging solutions across various healthcare sectors.

For instance, in November 2024, Nelipak Corporation, a leading global provider of packaging solutions for medical devices, diagnostic, pharmaceutical drug delivery, and other demanding applications, opened its first North American flexible packaging production site, in Winston-Salem, NC. The addition of the new production site will replicate Nelipak's existing capabilities to support growing customer demand in the Americas region.

Asia-Pacific is growing at the fastest pace in the healthcare protective packaging market

Asia Pacific economies are expanding rapidly with significant GDP growth, particularly in countries like China and India. This economic growth has led to increased healthcare spending as governments and consumers prioritize access to healthcare services. The rise in healthcare expenditure is directly boosting demand for protective packaging solutions to ensure the safety and efficacy of pharmaceuticals and medical devices.

For instance, China, as a major contributor to the market, is expected to see robust growth due to increased healthcare investments from both the government and private sectors. The demand for high-quality packaging materials to safeguard drugs and medical devices during distribution and storage is driving market expansion.

There is a growing awareness of environmental sustainability in the Asia Pacific, driving demand for eco-friendly packaging solutions. This is reflected in the adoption of recyclable plastics and biodegradable materials, particularly in countries like Japan, where stringent environmental regulations are in place.

For instance, in July 2024, the Council of Scientific and Industrial Research (CSIR) launched a National Mission on Sustainable Packaging Solutions. CSIR-National Institute for Interdisciplinary Science and Technology (NIIST), is tasked with coordinating the project that involves a consortium of eight partnering CSIR labs and industry partners.

Competitive Landscape

The major global players in the healthcare protective packaging market include SCHOTT Pharma AG & Co. KGaA, Gerresheimer AG, Amcor plc, Berry Global Inc., West Pharmaceutical Services, Inc., Smurfit Kappa, Sonoco Products Company, WestRock Company, DuPont, Pregis LLC and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global healthcare protective packaging market report delivers a detailed analysis with 70 key tables, more than 67 visually impactful figures, and 179 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Packaging Type
  • 2.4. Snippet by Material
  • 2.5. Snippet by Product Type
  • 2.6. Snippet by Application
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Focus on Sustainability
      • 3.1.1.2. Rising Advancements in Packaging
    • 3.1.2. Restraints
      • 3.1.2.1. Stringent Regulatory Compliance
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Healthcare Protective Packaging Market, By Packaging Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 5.1.2. Market Attractiveness Index, By Packaging Type
  • 5.2. Primary Packaging*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Secondary Packaging
  • 5.4. Tertiary Packaging

6. Healthcare Protective Packaging Market, By Material

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 6.1.2. Market Attractiveness Index, By Material
  • 6.2. Plastic*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Paper & Paperboard
  • 6.4. Glass
  • 6.5. Aluminium

7. Healthcare Protective Packaging Market, By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Bottles and Containers*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Blister Packaging
  • 7.4. Trays
  • 7.5. Vials
  • 7.6. Syringes
  • 7.7. Others

8. Healthcare Protective Packaging Market, By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Pharmaceuticals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Medical Devices
  • 8.4. Diagnostic Kits
  • 8.5. Nutraceuticals

9. Healthcare Protective Packaging Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
      • 9.2.7.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. SCHOTT Pharma AG & Co. KGaA*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
    • 11.1.5. SWOT Analysis
  • 11.2. Gerresheimer AG
  • 11.3. Amcor plc
  • 11.4. Berry Global Inc.
  • 11.5. West Pharmaceutical Services, Inc.
  • 11.6. Smurfit Kappa
  • 11.7. Sonoco Products Company
  • 11.8. WestRock Company
  • 11.9. DuPont
  • 11.10. Pregis LLC

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us